◀ Back to CYP19A1
CYP19A1 — FGF1
Text-mined interactions from Literome
Emoto et al., Proc Soc Exp Biol Med 1991
:
Although basic fibroblast growth factor ( 1-100 ng/ml ),
acidic fibroblast growth factor ( 1 ng/ml ), epidermal growth factor ( 1 ng/ml ), platelet derived growth factor ( 1 ng/ml ), tumor necrosis factor ( 1 ng/ml ), and transforming growth factor-beta 1 ( 1 ng/ml ) have no
effect on basal
aromatase activity in human skin fibroblasts, all of these growth factors inhibited the ability of dibutyryladenosine 3',5'-cyclic monophosphate to stimulate aromatase activity
Mendelson et al., Endocrinology 1986
:
Epidermal growth factor (EGF),
fibroblast growth factor ( FGF ) , and platelet derived growth factor ( PDGF ) were all without effect on aromatase activity when added by themselves, but markedly
inhibited aromatase activity stimulated by ( Bu ) 2cAMP
Raeside et al., Biochem Biophys Res Commun 1988
:
Stimulation of
aromatase activity in immature porcine Leydig cells by
fibroblast growth factor ( FGF ) ... The
effects of
fibroblast growth factor ( FGF ) on testicular
aromatase activity has been studied using primary cultures of porcine Leydig cells
McAllister et al., J Clin Endocrinol Metab 1994
:
In granulosa-lutein cells, forskolin stimulated
aromatase activity was
suppressed by EGF,
FGF , and TPA